pharma news today obesity drugs glp-1 october 2025 Novo abruptly ends drug deal with Hims GLP-1 Pipeline Update: August 2025

Neuromuscular function was determined via balance beam in females [Young ( n = 8), Old Con ( n = 12), and Old mAb ( n = 15)] and males [Young ( n = 8), Old Con ( n = 9), and Old mAb ( n = 9)]

This study showed for the first time that GDH-induced hypoglycemia was associated with impaired function of cells [12]

It can also reduce pigmentation, brighten skin tone, and give a clearer complexion

It helps produce the red blood cells that carry oxygen throughout our body

That has regularly been the case lately with GLP-1 drugs marketed by Novo Nordisk and Eli Lilly

BCL-2, the proto-oncogene, has the ability to block apoptosis, leading to reduced cell death and an enhanced proliferation (Westphal et al., 2014)